Evidence map›Paper›PMID 28746880›Full record

ArticleCell reports2017

TGF-β Signaling Is Necessary and Sufficient for Pharyngeal Arch Artery Angioblast Formation.

Maryline Abrial, Noëlle Paffett-Lugassy, Spencer Jeffrey, Daniel Jordan, Evan O'Loughlin, Charles J Frederick, C Geoffrey Burns, Caroline E Burns

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Zebrafish in Cardiovascular Disease Research: from Model to Application.International journal of biological sciences · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Temporal and Spatial Post-Transcriptional Regulation of ZebrafishArteriosclerosis, thrombosis, and vascular biology · 2018
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Maryline AbrialCardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA.
Noëlle Paffett-LugassyCardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA.
Spencer JeffreyCardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA 02129, USA.
Daniel JordanCardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA 02129, USA.
Evan O'LoughlinCardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA.
Charles J FrederickCardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA 02129, USA.
C Geoffrey BurnsCardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA. Electronic address: gburns@cvrc.mgh.harvard.edu.
Caroline E BurnsCardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA 02129, USA; Harvard Medical School, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA. Electronic address: cburns6@mgh.harvard.edu.
Harvard University · USMassachusetts General Hospital · US

Funding

Change of InstitutionR35HL135831 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI BURNS, CAROLINE E · 2017 to 2023
$4.2M
Genetic Determinants of Outflow Tract MorphogenesisR01HL096816 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI BURNS, C. GEOFFREY · 2010 to 2014
$2.2M
Harvard Stem Cell Institute Training Program for Pre- and Post-Doctoral FellowsT32HL087735 · NHLBI · HARVARD UNIVERSITY · PI SCADDEN, DAVID T · 2008 to 2012
$1.7M
Cellular and Genetic Determinants of Pharyngeal Arch Artery SpecificationF32HL112579 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI PAFFETT-LUGASSY, NOELLE NICOLE · 2013 to 2013
$58k
NHLBI NIH HHS F32 HL112579NHLBI NIH HHS R01 HL096816NHLBI NIH HHS R35 HL135831NHLBI NIH HHS T32 HL087735
6 · The paper itself

Abstract

The pharyngeal arch arteries (PAAs) are transient embryonic blood vessels that mature into critical segments of the aortic arch and its branches. Although defects in PAA development cause life-threating congenital cardiovascular defects, the molecular mechanisms that orchestrate PAA morphogenesis remain unclear. Through small-molecule screening in zebrafish, we identified TGF-β signaling as indispensable for PAA development. Specifically, chemical inhibition of the TGF-β type I receptor ALK5 impairs PAA development because nkx2.5

Indexed as

AnimalsArteriesBranchial RegionHomeobox Protein Nkx-2.5Signal TransductionTransforming Growth Factor betaZebrafishZebrafish ProteinsHomeobox Protein Nkx-2.5Nkx2.5 protein, zebrafishTransforming Growth Factor betaZebrafish Proteinscardiovasculargreat vesselsnkx2.5pharyngeal arch arterySmadsmall-molecule screenTGF-βzebrafish

Identifiers

PMID28746880
PMCPMC5565225
OpenAlexW2738319379

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.